发明名称 CEPHALOSPORIN SALTS AND INJECTABLE COMPOSITIONS
摘要 CRYSTALLINE SULFURIC, DI-NITRIC, MONO-HYDROCHLORIC, DI-HYDROCHLORIC, AND DI- AND SESQUI-ORTHOSPHOSPHORIC ACID ADDITION SALTS OF 7-[-(2-AMINOTHIAZOL-4-YL)--(Z)-METHOXYIMINO-ACETAMIDO]-3-[(1-METHYL-LPYRROLIDINIO) METHYL]-3-CEPHEM-4 CARBOXYLATE ARE STABLE EVEN AT ELEVATED TEMPERATURES. THE CRYSTALLINE SULFURIC ACID ADDITION SALT IS MADE BY FORMING AN ADMIXTURE OF (A) AT LEAST ONE MOLAR EQUIVALENT OF SULFURIC ACID WITH (B) ZWITTERION IN AN AMOUNT SO AS TO BE PRESENT IN THE ADMIXTURE AT A CONCENTRATION OF GREATER THAN 25 MILLIGRAMS/ML, CAUSING CRYSTALLIZATION, SEPARATING THE CRYSTALS, WASHING AND DRYING. THE CRYSTALLINE MONOHYDROCHLORIDE, DIHYDROCHLORIDE, AND ORTHOPHOSPHATE SALTS ARE PREPARED BY DISSOLVING THE ZWITTERION IN THE APPROPRIATE AMOUNT OF ACID, CAUSING CRYSTALLIZATION BY ADDING ACETONE AND ISOLATING THE CRYSTALS. PHYSICAL ADMIXTURES OF THE SALTS WITH CERTAIN BASES IN PROPORTIONS TO GIVE A PH RANGING FROM ABOUT 3.5 TO ABOUT 7 ON DILUTION WITH WATER PROVIDE INJECTABLE COMPOSITIONS ON DILUTION.
申请公布号 MY116452(A) 申请公布日期 2004.02.28
申请号 MYPI8900050 申请日期 1989.01.16
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 MURRAY ARTHUR KAPLAN;ROBERT ALAN LIPPER;KUN MAO SHIH;SUSAN D. BOETTGER;THOMAS W. HUDYMA
分类号 A61K31/545;C07D501/00;C07D501/38;C07D501/46 主分类号 A61K31/545
代理机构 代理人
主权项
地址